Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future
Agnieszka Łoboda, Józef Dulak
Pharmacological Reports (2020) Vol. 72, Iss. 5, pp. 1227-1263
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Challenges Posed by Immune Responses to AAV Vectors: Addressing Root Causes
Bradley A. Hamilton, J. Fraser Wright
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 77
Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research
Kalina Andrysiak, Jacek Stępniewski, Józef Dulak
Pflügers Archiv - European Journal of Physiology (2021) Vol. 473, Iss. 7, pp. 1061-1085
Open Access | Times Cited: 61
Innovative Therapeutic Approaches for Duchenne Muscular Dystrophy
F. Fortunato, Rachele Rossi, Maria Sofia Falzarano, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 820-820
Open Access | Times Cited: 57
Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders
Sibylle Jablonka, Luisa Hennlein, Michael Sendtner
Neurological Research and Practice (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 51
Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper
Tong‐Yuan Yang, Manuela Braun, Wibke Lembke, et al.
Molecular Therapy — Methods & Clinical Development (2022) Vol. 26, pp. 471-494
Open Access | Times Cited: 48
Early Cardiac Dysfunction in Duchenne Muscular Dystrophy: A Case Report and Literature Update
Maria Lupu, Irina Pintilie, Raluca Ioana Teleanu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1685-1685
Open Access | Times Cited: 1
Long-term culture of patient-derived cardiac organoids recapitulated Duchenne muscular dystrophy cardiomyopathy and disease progression
Vittoria Marini, Fabiola Marino, Flaminia Aliberti, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 28
The multifaceted view of heart problem in Duchenne muscular dystrophy
Urszula Florczyk, Katarzyna Polak, Józef Dulak
Cellular and Molecular Life Sciences (2021)
Open Access | Times Cited: 34
The Perspective of DMPK on Recombinant Adeno-Associated Virus-Based Gene Therapy: Past Learning, Current Support, and Future Contribution
Nancy Chen, Kefeng Sun, Nagendra Chemuturi, et al.
The AAPS Journal (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 24
Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy
Alicja Starosta, Patryk Konieczny
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 11, pp. 4867-4891
Open Access | Times Cited: 27
Single-cut gene therapy in a one-step generated rhesus monkey model of Duchenne muscular dystrophy
Raoxian Bai, Wenting Guo, Ting Zhang, et al.
Cell Reports Medicine (2025), pp. 102037-102037
Open Access
Glucocorticoides y manejo cardíaco en pacientes con distrofia muscular de Duchenne
Edna Julieth Bobadilla-Quesada, Manuel Huertas-Quiñones, Juan David Lasprilla Tovar, et al.
Revista Ciencias de la Salud (2025) Vol. 23, Iss. Especial, pp. 1-13
Open Access
The effects of glucocorticoids on cardiac function of patients with Duchenne muscular dystrophy: benefit or not?
Yaru Cui, Shuran Shao, Linling Zhang, et al.
European Journal of Pediatrics (2025) Vol. 184, Iss. 5
Open Access
Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy
Maria Siemionow, Paulina Langa, Sonia Brodowska, et al.
Stem Cell Reviews and Reports (2022) Vol. 18, Iss. 8, pp. 2872-2892
Open Access | Times Cited: 17
Cardioprotective Effects of Hydrogen Sulfide and Its Potential Therapeutic Implications in the Amelioration of Duchenne Muscular Dystrophy Cardiomyopathy
Agnieszka Łoboda, Józef Dulak
Cells (2024) Vol. 13, Iss. 2, pp. 158-158
Open Access | Times Cited: 3
Electrophysiologic and cardiovascular manifestations of Duchenne and Becker muscular dystrophies
Matthew Hakimi, Tyson Burnham, J. A. Ramsay, et al.
Heart Rhythm (2024)
Open Access | Times Cited: 3
Myogenic Cell Transplantation in Genetic and Acquired Diseases of Skeletal Muscle
Olivier Boyer, Gillian Butler‐Browne, Hector Chinoy, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 22
A Decade of Progress in Gene Targeted Therapeutic Strategies in Duchenne Muscular Dystrophy: A Systematic Review
Lam Chung Liang, Nadiah Sulaiman, Muhammad Dain Yazid
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 14
Safety and Efficacy of DT-DEC01 Therapy in Duchenne Muscular Dystrophy Patients: A 12 - Month Follow-Up Study After Systemic Intraosseous Administration
Maria Siemionow, Grzegorz Biegański, Adam Niezgoda, et al.
Stem Cell Reviews and Reports (2023) Vol. 19, Iss. 8, pp. 2724-2740
Open Access | Times Cited: 8
Anti-Fibrotic Effect of Human Wharton’s Jelly-Derived Mesenchymal Stem Cells on Skeletal Muscle Cells, Mediated by Secretion of MMP-1
A Hyun Choi, Sang Eon Park, Jang Bin Jeong, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6269-6269
Open Access | Times Cited: 19
Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy
Olga Mucha, Paulina Podkalicka, Katarzyna Kaziród, et al.
Skeletal Muscle (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 17
Therapeutic approaches to preserve the musculature in Duchenne Muscular Dystrophy: The importance of the secondary therapies
Giuseppe Angelini, Giada Mura, Graziella Messina
Experimental Cell Research (2021) Vol. 410, Iss. 2, pp. 112968-112968
Closed Access | Times Cited: 17
Age-Dependent Dysregulation of Muscle Vasculature and Blood Flow Recovery after Hindlimb Ischemia in the mdx Model of Duchenne Muscular Dystrophy
Paulina Podkalicka, Olga Mucha, Katarzyna Kaziród, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 481-481
Open Access | Times Cited: 16
miR-378 affects metabolic disturbances in the mdx model of Duchenne muscular dystrophy
Paulina Podkalicka, Olga Mucha, Katarzyna Kaziród, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases
Katarzyna Kaziród, Małgorzata Myszka, Józef Dulak, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 12
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top